Thermo Fisher launches LDT to support tailored immunosuppressant dosing
Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.

Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.
Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.
Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.
Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.
PanMETAI analyses up to 260,000 molecular signals per individual using a standardised NMR approach.
The trial involved 14 participants, with multiple operators conducting several measurements on each of them.
Chronic GvHD is a serious complication of allogeneic haematopoietic stem cell transplantation (HSCT).
The systems offer enhanced imaging, wireless Vscan Air, and diagnostic accuracy across multiple care areas.
Quantum Surgical has developed the Epione robotic platform for early-stage tumour interventions.
The qCXL platform employs a customised treatment planning engine and real-time ultrasound monitoring for precision.
The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic.
The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural complexity.
Learn more about Alleima’s life changing medical-solutions